HERM Seminar series

1 September (15:00-16:00)

Title: Lessons from Somatic genetic rescue in Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasms

• Speaker: Jörg Cammenga, MD, PhD,  Department of Hematology, Department of Molecular Medicine and Gene Therapy, Stem Cell Center Lund, Lund University Hospital and Lund University.
   
• Host: Eva Hellström Lindberg, HERM, MedH, KI.

3 September

Joint HERM/KiSS seminar: Discovering rare antibodies to combat malaria

• Speaker: Joshua Tan, PhD, NIH.
   
• Host: Antonino Cassotta, HERM, MedH, KI.

14 September

Title: TBA

• Speaker: Yannick Simoni, PhD, Institut Cochin.
   
• Host: Isabelle Magalhaes, HERM, MedH, KI.

22 September

Title: TBA

• Speaker: Michela Bardini, University of Milano.
   
• Host: Andreas Lennartsson, HERM, MedH, KI.

1 October

Title: Insights on evolutionary dynamics of leukemia from large patient cohorts

• Speaker: Raphaël Itzykson, MD, PhD, Hematology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Leukemia Institute Paris Saint-Louis, Saint-Louis Institute for Research INSERM UMR1342
   
• Host: Johanna Ungerstedt, HERM, MedH, KI.

5 October

Title: TBA

• Speaker: Mariolina Salio, Immunocore.
   
• Host: Antonino Cassotta, HERM, MedH, KI.

TBA

TBA

19 January

Title: Thread of excess: RNA control of metabolite fate

• Speaker: Claudia Kutter, Principal Researcher, Department of Microbiology, Tumor and Cell Biology, KI.
   
• Host: Sören Lehmann, HERM, MedH, KI.

26 January

Title: Pain neurons control cancer immunosurveillance

• Speaker: Sébastien Talbot, Principal Researcher, Department of Physiology and Pharmacology, KI.
   
• Host: Nicole Marquardt, HERM, MedH, KI.

9 February

HERM seminar series - “Tissue-Resident Memory T Cells: Adaptation, Plasticity, and Therapeutic Implications"

• Speaker: Thomas Müller, Assistant Professor, HERM, MedH, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

12 February, 15:00-16:00

Title: Genetic diversity of congenital neutropenia: Implications for malignant transformation to MDS/AML

• Speaker: Professor Ivo Touw, Erasmus MC, the Netherlands.
   
• Host: Eva Hellström Lindberg, HERM, MedH, KI.

16 February

Title: High‑throughput approaches for evaluating functional consequences of disease‑associated genetic variants and programming proteome–epigenome interactions

• Speaker: Karl Carlström, Assistant Professor, Department of Laboratory Medicine, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

2 March

Title: Type 2 Immunity Holds Key to Cancer Cure? The Journey from Bench to Bedside and Back

• Speaker: Li Tang
  Associate Professor, Institute of Bioengineering (IBI) / Institute of Materials Science & Engineering (IMX) / Vice Dean for Innovation, School of Life Sciences, École polytechnique fédérale de Lausanne (EPFL)
• Host: Yenan Bryceson, HERM, MedH, KI.

9 March

Title: Signal integration in cytotoxic lymphocytes during infection

• Speaker: Simon Grassman, M.D., Immunology Program, Memorial Sloan Kettering Cancer Center, USA
   
• Host: Thomas Müller, HERM, MedH, KI.

16 March

Title: Precision engineering of cell fates via data-driven multi-gene control of transcriptional networks

• Speaker: Jens Magnusson, Assistant Professor, Department of Laboratory Medicine, KI.
   
• Host: Yenan Bryceson, HERM, MedH, KI.

23 March

Title: Radiopharmaceuticals and their anti-tumor immunity

• Speaker: Zhibo Liu, Professor and Chair of Applied Chemistry, Peking University. Leading scientist at Changping Laboratory, China. 
   
• Host: Hong Qian, HERM, MedH, KI.

30 March

Title: Interplay of clonal landscape and its remodeling in MDS and MPN undergoing transplantation

• Speaker: Nico Gagelmann, MD, PhD, Dana Farber Cancer Institute, Boston, MA and University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

13 April

Title: Group 2 innate lymphoid cells in the regulation of normal and malignant hematopoiesis

• Speaker: Sergio Martinez-Høyer, Division of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, KI.
   
• Host: Andreas Lennartsson, HERM, MedH, KI.

27 April

Title: Tissue-resident memory T cells in autoimmune rheumatic diseases

• Speaker: Karine Chemin, Docent, CMM, MedS, KI.
   
• Host: Isabelle Magalhaes, HERM, MedH, KI.

18 May

Title: Inducing tumor-specific T cell responses in absence  of CD28 ligands and immune-checkpoint inhibitors

• Speaker: Bernard Malissen, Centre d'Immunologie de Marseille Luminy (CIML).
   
• Host: Yenan Bryceson, HERM, MedH, KI.

25 May

Title: CAR T-cell therapy at Karolinska: Current status and future developments

• Speaker: Stephan Mielke, Professor, Department of Laboartory Medicine, KI
  Center for Allogen Stemcell Transplantation (CAST), Karolinska University hospital Huddinge
  Director of the Cellular Therapy and Allogeneic Stem Cell Transplantation Program (JACIE)
  Member of Board of Directors of Karolinska Comprehensive Cancer Center (OECI) and Karolinska ATMP Center Karolinska Institutet and University Hospital
   
• Host: Magnus Tobiasson, HERM, MedH, KI.

26 May

Title: Arrested development: cell dynamics in human NK cell differentiation

• Speaker: Emily Mace, Department of Paediatrics, Columbia University Medical Center, New York, USA
   
• Host: Tessa Campbell, HERM, MedH, KI.

1 June

Title: How T-cells cure cancer: Lessons from successful immunotherapy?

• Speaker: Professor Andrew Sewell, Distinguished Research Professor and Wellcome Trust Senior Investigator; Division of Infection and Immunity Cardiff University School of Medicine; Visiting Professor, Kumamoto University.
   
• Host: Antonino Cassotta, HERM, MedH, KI.

15 June

Title: Leukemia stem cells in disease evolution and persistence

• Speaker: Professor Ravi Bhatia, MD, Division of Hematology and Oncology, Department of Medicine at the University of Alabama at Birmingham (UAB) and the John G Kelton MD Endowed Chair in Hematology and Oncology.
   
• Host: Hong Qian, HERM, MedH, KI.